Class I and III antiarrhythmic drugs for prevention of sudden cardiac death and management of postmyocardial infarction arrhythmias. A review.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23681306)

Published in Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub on May 07, 2013

Authors

Milan Vrana1, Jiri Pokorny, Pavel Marcian, Zdenek Fejfar

Author Affiliations

1: Experimental Department and Department for Medical Electronics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. milan.vrana@centrum.cz